CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3027% below fair value
$49.35−1.24 (-2.45%)
Close on Nov 16, 2026Market cap $1.47BP/E 20.4Yield 1.22%
Conmed operating margin
Operating margin is operating income as a percentage of revenue.
Conmed's operating margin for the twelve months ending Sep 30, 2026 was 9.9%. For fiscal 2025 it was 7.5%, against 15.3% the year before. The highest annual figure on record is 15.3% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.5% | −7.9 |
| FY2024 | Dec 31, 2024 | 15.3% | +5.6 |
| FY2023 | Dec 31, 2023 | 9.7% | +3.0 |
| FY2022 | Dec 31, 2022 | 6.7% | −4.2 |
| FY2021 | Dec 31, 2021 | 10.9% | +5.5 |
| FY2020 | Dec 31, 2020 | 5.3% | −2.9 |
| FY2019 | Dec 31, 2019 | 8.3% | −0.0 |
| FY2018 | Dec 31, 2018 | 8.3% | +2.4 |
| FY2017 | Dec 31, 2017 | 5.9% | +1.0 |
| FY2016 | Dec 31, 2016 | 4.9% | −2.2 |
| FY2015 | Dec 31, 2015 | 7.1% | −0.0 |
| FY2014 | Dec 31, 2014 | 7.1% | −0.3 |
| FY2013 | Dec 31, 2013 | 7.4% | −1.1 |
| FY2012 | Dec 31, 2012 | 8.5% | +7.4 |
| FY2011 | Dec 31, 2011 | 1.1% | −6.9 |
| FY2010 | Dec 31, 2010 | 8.0% | +3.9 |
| FY2009 | Dec 31, 2009 | 4.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 11.1% | +7.6 |
| Q2 FY2026 | Jun 30, 2026 | 10.6% | −0.5 |
| Q1 FY2026 | Mar 31, 2026 | 8.0% | +3.0 |
| Q4 FY2025 | Dec 31, 2025 | 9.8% | −5.4 |
| Q3 FY2025 | Sep 30, 2025 | 3.5% | −17.2 |
| Q2 FY2025 | Jun 30, 2025 | 11.1% | −3.0 |
| Q1 FY2025 | Mar 31, 2025 | 5.0% | −6.2 |
| Q4 FY2024 | Dec 31, 2024 | 15.2% | −0.2 |
| Q3 FY2024 | Sep 30, 2024 | 20.7% | +10.8 |
| Q2 FY2024 | Jun 30, 2024 | 14.2% | +5.6 |
| Q1 FY2024 | Mar 31, 2024 | 11.2% | +6.9 |
| Q4 FY2023 | Dec 31, 2023 | 15.3% | +15.8 |
| Q3 FY2023 | Sep 30, 2023 | 9.9% | +1.1 |
| Q2 FY2023 | Jun 30, 2023 | 8.6% | −0.2 |
| Q1 FY2023 | Mar 31, 2023 | 4.3% | −5.0 |
| Q4 FY2022 | Dec 31, 2022 | -0.4% | −14.0 |
| Q3 FY2022 | Sep 30, 2022 | 8.8% | −1.9 |
| Q2 FY2022 | Jun 30, 2022 | 8.8% | −1.3 |
| Q1 FY2022 | Mar 31, 2022 | 9.3% | +0.6 |
| Q4 FY2021 | Dec 31, 2021 | 13.6% | +3.8 |
| Q3 FY2021 | Sep 30, 2021 | 10.7% | −1.6 |
| Q2 FY2021 | Jun 30, 2021 | 10.1% | +23.5 |
| Q1 FY2021 | Mar 31, 2021 | 8.6% | +2.5 |
| Q4 FY2020 | Dec 31, 2020 | 9.8% | −0.8 |
| Q3 FY2020 | Sep 30, 2020 | 12.4% | +3.4 |
| Q2 FY2020 | Jun 30, 2020 | -13.5% | −21.3 |
| Q1 FY2020 | Mar 31, 2020 | 6.2% | +0.8 |
| Q4 FY2019 | Dec 31, 2019 | 10.5% | −0.1 |
| Q3 FY2019 | Sep 30, 2019 | 9.0% | +3.3 |
| Q2 FY2019 | Jun 30, 2019 | 7.8% | −0.0 |
| Q1 FY2019 | Mar 31, 2019 | 5.3% | −3.2 |
| Q4 FY2018 | Dec 31, 2018 | 10.7% | +0.2 |
| Q3 FY2018 | Sep 30, 2018 | 5.7% | −1.4 |
| Q2 FY2018 | Jun 30, 2018 | 7.8% | +1.4 |
| Q1 FY2018 | Mar 31, 2018 | 8.6% | +9.9 |
| Q4 FY2017 | Dec 31, 2017 | 10.4% | +4.2 |
| Q3 FY2017 | Sep 30, 2017 | 7.1% | – |
| Q2 FY2017 | Jun 30, 2017 | 6.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -1.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 6.2% | – |
See a number that looks wrong?